The FDA approved a new pharmaceutical drug as prevention against Covid-19. The doctor in charge of the research and development department at DHR tells us who qualifies and what this new process is about.
The Evusheld doses is to prevent Sars-Cov-2 and it differentiates from the rest of the other injections because this one helps people who have a weak immune system, prevent Covid. Dr. Rao talks to us about what this new vaccine is about.
“Two separate molecula antibodies both are directed against the receptive binding domain, or the s-bind domain, which is the virus that binds to human cells. It actually directly impacts that particular region which is a binding to the human cells, which prevents the virus from binding,” said Dr. Rao.